Phase 1 Unit
Phase 1 Clinical Trial Unit
Our Cypress, CA clinical pharmacology unit is designed specifically for early clinical development and is uniquely positioned to meet your high-volume enrollment needs.
Phase 1 Clinical Unit Facility Tour
Purpose Built for Early Clinical Development
With 80,000 sq. ft. and 180 beds, this clinical pharmacology unit is dedicated to early phase clinical development trials involving short-term or long-term overnight confinement, serial sampling and surveillance, and in populations such as normal healthy volunteers and those of Asian descent for Ethnobridging clinical trials.
The Phase 1 clinical trials unit is uniquely positioned between the Orange County and Los Angeles County, giving us the ability to strategically recruit diverse populations from three large metropolitan areas that are home to nearly 18 million people:
Los Angeles County (population: ~10MM)
Orange County (population: ~3.2MM)
Riverside/San Bernardino Counties: (population: ~4.6MM)
Many clinical trial volunteers are also available for recruitment from multiple universities nearby. To ensure the success of your study’s enrollment, the Phase 1 clinical trial unit’s active outreach team aids community clinical research education and augments our overall patient recruitment efforts. Learn more about our strategies for identifying clinical trial volunteers here.
Clinical Pharmacology Unit Highlights
- 250 employees trained for Emergency Response situations
- Various COVID-19 screening platforms
- On-site CAP and CLIA-accredited Safety Reference Laboratory capable of conducting hundreds of tests important for early clinical development
- Peripheral Blood Mononuclear Cell (PBMC) processing capabilities
- USP 797/800-compliant sterile room for parenteral drug preparation
- 850 sq. ft. dual chambers with fully enclosed, isolated air venting systems for clinical testing of inhaled or aerosol products
- First-in-Human (FIH)/First-in-Man (FIM) trials
- Single Ascending Dose/Multiple Ascending Dose (SAD/MAD) trials
- Assessment of Pharmacokinetics /Pharmacodynamics (PK/PD)
- Establishing Bioavailability/Bioequivalence (BA/BE)
- Biosimilar
- Drug-Drug Interaction (DDI) trials
- Drug delivery
- Device
- Food Effect (FE) trials
- Cardiac safety & Thorough QT/QT prolongation studies (TQT)
Special procedures performed:
- Bronchoscopy
- Bio-fluid collection: stool, sputum, semen, emesis, urine, CSF
- Biopsies
- Cystoscopy
- Glucose monitoring
- Holter Monitoring & Telemetry
- Skin testing
- Pulmonary function testing including Bronchial Challenge Testing
- Vaginal ultrasounds and pap smears
- Various ophthalmic tests
- X-rays & MRIs
Submit RFI/RFP
Tell us about your study to receive a customized proposal.
Early Clinical Development
Early Clinical Development Resources
With over 600 Phase 1 clinical trials completed for the development of specialized therapies and medicines, WCCT has developed a comprehensive portfolio of expertise in early clinical development
10 Questions to Ask Clinical Phase 1 Units
It’s not unusual for Sponsors to establish shortlists of clinical Phase 1 units. What questions should they be asking to ensure the best overall study?
Reduce the Cost of Phase 1 Clinical Trials
How can Sponsors reduce the cost of Phase 1 clinical trials? A deep analysis of a Phase 1 site’s operations and staffing procedures is the answer.
8 Questions to Ensure Successful Patient Recruitment in Phase 1 Clinical Trials
WCCT put together a list of items to consider when conducting phase 1 studies with patient population or specialty population.
Webinar: Phase 1 Patient Study Recruitment
WCCT hosted a webinar discussing achieving endpoints and Phase 1 Trial objectives through superior volunteer management. Three experts share their strategies and experience.
E-book: Conduct Your Phase 1 Trial Right the First Time
A Professional Guide for Clinical Trial Personnel, which sets forth standards for design, conduct, and monitoring of early phase trials in several short reads.
Diversity of clinical trial participation in early-phase clinical trials
WCCT introduces its strategies and tactics to ensure ethnic diversity in the participation of clinical trials.
GET IN TOUCH
SUBMIT RFI/RFP
NEWS AND BLOG